Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 33, Issue 3, 2008, Pages 181-186

  Duborija Kovacevic, Natasha ^a   Jakovljevic, V ^b   Sabo, A ^b   Tomic, Z ^b  

^a UNIVERSITY OF MONTENEGRO   (Montenegro)

^b Medical School of the University in Novi Sad   (Serbia)

Author keywords

Analgesia; Benign prostatic hyperplasia; Finasteride; Inflammation

Indexed keywords

FINASTERIDE; MORPHINE; OLIVE OIL; STEROID 5ALPHA REDUCTASE INHIBITOR; UNCLASSIFIED DRUG; WATER; ZERLON;

ANALGESIA; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; MALE; NONHUMAN; PAIN; PATHOGENESIS; PAW EDEMA; PROSTATE HYPERTROPHY; RAT; STEROIDOGENESIS; TAIL FLICK TEST; TREATMENT DURATION; WISTAR RAT;

EID: 56249101728     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03191116     Document Type: Article

References (18)

1. Andersen J.T., Nickel J.C., Marshall V.R., Schulman C.C. Boyle P. (1997): Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology, 49, 839-845.
2. Schafer W., Tammela T.L., Barrett D.M. et al (1999): Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Finasteride Urodynamics Study Group. Urology, 54, 278-283.
3. Andersen J.T., Wolf H., Ekman P. et al. (1996): Finanseride in symptomatic benign prostatic hypertrophy. A 2-year placebo-controlled study. Ugeskr. Laeger., 158, 5030-5035.
4. Gormley G.J., Stoner E., Bruskewitz R.C. et al. (1992): The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N. Engl. J. Med., 327, 1185-1191.
5. Rhodes M.E., Frye C.A. (2001): Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn. Affect Behav. Neurosci., 1(3), 287-296.
6. Poletti A. et al. (1998): 5 alpha-reductase isozymes in the central nervous system. Steroids, 63(5-6), 246-251.
7. Patte-Mensah C., Penning T.M., Mensah-Nyagan A.G. (2004): Anatomical and cellular localization of neuroactive 5alpha/3alpha-reduced steroid-synthesizing enzymes in the spinal cord. J. Comp. Neurol., 477, 286-299.
8. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., Peters J.A. (2003): Neurosteroid modulation of GABAA receptors Prog. Neurobiol., 71, 67-80.
9. Bortolato M., Frau R., Orru M. et al (2008): Antipsychotic-Like Properties of 5-alpha-Reductase Inhibitors. Neuropsychopharmacology.
10. Amini H., Ahmadiani A. (2005): In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure. Int. J. Dev. Neurosci., 23, 621-626.
11. Verdi J., Ahmadiani A. (2007): Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat. Horm. Behav., 51, 605-610.
12. Lee Keith L., Peehl Donna M. (2004): Molecular and cellular pathogenesis of benign prostatic hyperplasia. J. Urol., 172, 1784-1791.
13. Untergasser G., Madersbacher S., Berger P. (2005): Benign prostatic hyperplasia: age-related tissue-remodeling. Exp. Gerontol., 40, 121-128.
14. Kramer G., Marberger M. (2006): Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr. Opin. Urol., 16, 25-29.
15. D'Amour F.E., Smith D.L. (1941): A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
16. Sauver J.L., Jacobson D.J., McGree M.E., Lieber M.M., Jacobsen S.J. (2006): Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia. Am. J. Epidemiol., 164. 760-768.
17. Wieseler-Frank J., Maier S.F., Watkins L.R. (2005): Immune-to-brain communication dynamically modulates pain: Physiological and pathological consequences. Brain Behav. Immun., 19, 104-111.
18. D'Mello R., Dickenson A.H. (2008): Spinal cord mechanisms of pain. Br. J. Anaesth.